CME Group Inc. (NASDAQ:CME) Shares Bought by Rathbones Group PLC

Rathbones Group PLC boosted its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 3.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,311,474 shares of the financial services provider's stock after acquiring an additional 46,276 shares during the quarter. CME Group comprises 1.4% of Rathbones Group PLC's holdings, making the stock its 16th largest holding. Rathbones Group PLC owned approximately 0.36% of CME Group worth $257,836,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Gold Investment Management Ltd. acquired a new stake in CME Group in the 4th quarter valued at approximately $26,000. Salomon & Ludwin LLC purchased a new stake in shares of CME Group in the 1st quarter valued at $28,000. Y.D. More Investments Ltd purchased a new stake in shares of CME Group in the 2nd quarter valued at $36,000. Rise Advisors LLC acquired a new position in CME Group during the 1st quarter worth about $41,000. Finally, McClarren Financial Advisors Inc. boosted its holdings in CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider's stock valued at $39,000 after acquiring an additional 78 shares during the period. Institutional investors and hedge funds own 87.75% of the company's stock.

Insider Buying and Selling at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the firm's stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.30% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have issued reports on CME shares. Deutsche Bank Aktiengesellschaft boosted their price target on shares of CME Group from $193.00 to $200.00 and gave the stock a "hold" rating in a research note on Thursday, August 15th. Barclays boosted their price target on shares of CME Group from $208.00 to $209.00 and gave the stock an "equal weight" rating in a research note on Thursday, July 25th. Bank of America cut CME Group from a "neutral" rating to an "underperform" rating and reduced their price objective for the company from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Piper Sandler reissued an "overweight" rating and set a $225.00 target price on shares of CME Group in a research note on Tuesday, August 20th. Finally, JPMorgan Chase & Co. increased their price target on CME Group from $187.00 to $191.00 and gave the company an "underweight" rating in a research report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, CME Group presently has a consensus rating of "Hold" and a consensus price target of $209.73.

CME Group Stock Performance

Shares of CME stock traded down $0.31 during mid-day trading on Friday, hitting $216.99. 2,587,260 shares of the stock were exchanged, compared to its average volume of 1,952,728. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $223.80. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market capitalization of $78.13 billion, a price-to-earnings ratio of 24.69, a P/E/G ratio of 8.85 and a beta of 0.55. The stock's fifty day simple moving average is $205.69 and its two-hundred day simple moving average is $207.50.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.53 by $0.03. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company's revenue for the quarter was up 12.7% compared to the same quarter last year. During the same period last year, the firm posted $2.30 earnings per share. On average, analysts forecast that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be given a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.12%. CME Group's payout ratio is 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.